Home » Sun Pharma, Ranbaxy Face U.S. Recalls
Sun Pharma, Ranbaxy Face U.S. Recalls
Indian generics makers Sun Pharma and Ranbaxy are both facing individual Class II U.S. recalls related to product mixups.
Drug Daily Bulletin
Drugs Postmarket Safety Quality Regulatory AffairsDrug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May